Understanding Radiation Dose Fractionation

In modern oncology, radiation therapy is a cornerstone of cancer treatment. However, prescribing radiation is not as simple as giving a patient a total physical dose (e.g., 60 Gray) all at once. Delivering a massive dose in a single burst causes catastrophic damage to healthy tissue. To protect the patient, radiation oncologists use fractionation — splitting the total dose into small daily treatments delivered over several weeks. This Radiation Dose Fractionation Calculator uses the Linear-Quadratic (LQ) model to compute the true biological effect of any schedule, returning the Biologically Effective Dose (BED) and the Equivalent Dose in 2 Gy fractions (EQD2).

Why We Fractionate Radiation

The success of radiotherapy rests on a biological asymmetry known as the therapeutic index. Normal cells possess highly efficient DNA repair mechanisms. After a small dose such as 2 Gray, both the tumor and the healthy tissue suffer DNA damage, but within roughly 24 hours the healthy tissue has largely repaired its sublethal damage while the chaotic, rapidly dividing tumor cells — with defective repair — accumulate permanent injury. Daily fractions exploit that difference: healthy tissue continually recovers between treatments, and the tumor does not.

Fractionation also exploits the oxygen effect: well-oxygenated tissue is more radiosensitive, and a fractionated course allows transiently hypoxic (oxygen-poor) tumor regions to reoxygenate between doses, making subsequent fractions more effective. Both mechanisms — repair and reoxygenation — are bought with the one currency this calculator quantifies: how much biological damage a given physical dose does to each tissue type.

The Linear-Quadratic (LQ) Model

The LQ model is the mathematical foundation of modern radiobiology. It states that radiation kills cells through two distinct mechanisms. The alpha (linear) component represents a single track breaking both DNA strands simultaneously — damage that is unrepairable and proportional to total dose regardless of fraction size. The beta (quadratic) component represents two separate tracks, each breaking one strand close in space and time, which jointly form a double-strand break. The quadratic term depends on the square of the dose, which is why the size of each fraction matters: big fractions disproportionately increase beta-type damage.

The alpha/beta ratio is the dose at which the two contributions are equal, and it is the single input that determines how a tissue reacts to fractionation. Values of 10 Gy or higher describe most tumors and early-responding tissues — driven by total dose, insensitive to fraction size. Values around 3 Gy describe late-responding normal tissues such as spinal cord, brain, kidney, and connective tissue — driven by fraction size, and damaged disproportionately by large daily doses.

Biologically Effective Dose (BED)

Physical dose cannot be compared across schedules. Sixty Gray in 30 fractions of 2 Gy is a routine, well-tolerated prostate regimen; sixty Gray in 3 fractions of 20 Gy would be a catastrophe for surrounding tissue. BED solves the comparison by weighting total dose with a fraction-size term: BED equals D times one plus d over alpha/beta. Because the formula contains alpha/beta, BED is tissue-specific — a single schedule has a tumor BED and a different normal-tissue BED, and the gap between them is a measure of how much therapeutic room the schedule has.

Equivalent Dose in 2 Gy Fractions (EQD2)

Clinicians have spent decades accumulating intuition in one language: the 2 Gy daily fraction. The spinal cord tolerates roughly 45 to 50 Gy in 2 Gy fractions before the risk of myelopathy becomes serious; the brain similarly. EQD2 translates any other schedule into that familiar currency: it asks what total dose delivered at 2 Gy per fraction would produce the same biological effect as the schedule being evaluated.

The practical value is immediate. When a hypofractionated lung SBRT plan is checked, the physician does not ask “is 12 Gy times 4 safe for the esophagus?” in that unfamiliar form. The plan is converted to the esophageal EQD2, compared against the decades-old tolerance tables, and judged in the language those tables were written in. This calculator performs exactly that conversion for both a tumor and a normal tissue, side by side, so the therapeutic ratio of the schedule is visible in one view.

Clinical Uses: Hypofractionation and SBRT

Prostate cancer used to mean eight weeks of daily treatment. Modern evidence supports moderate hypofractionation — 60 Gy in 20 fractions, or 70 Gy in 28 — with the same tumour control and acceptable toxicity, cutting clinic visits nearly in half. Stereotactic body radiotherapy pushes further, delivering 8 Gy or more per fraction in three to five sessions for lung, spine, and liver lesions. Because BED grows faster than linearly with fraction size, an 8 Gy fraction is far more than four times as biologically potent as a 2 Gy fraction, which is how small physical doses achieve high tumor control.

The same nonlinearity is why SBRT is only safe with precision delivery. The normal tissue around a lesion still receives the large fraction, and its low alpha/beta ratio converts that dose into a punishing EQD2. The technique succeeds because image guidance and rapid dose fall-off confine the large fractions to a small volume of normal tissue — a three-dimensional judgement this two-point model cannot make for you. Use the numbers it produces to understand the biology, and leave the plan design to the radiation oncology team.